Yuming Rong
Overview
Explore the profile of Yuming Rong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fan T, Huang Y, Liu Z, Huang J, Ke B, Rong Y, et al.
Drug Des Devel Ther
. 2024 Apr;
18:1115-1131.
PMID: 38618280
Background: The ChaiShao Shugan Formula (CSSGF) is a traditional Chinese medicine formula with recently identified therapeutic value in triple-negative breast cancer (TNBC). This study aimed to elucidate the underlying mechanism...
2.
Li X, Huang L, Yan Y, Rong Y, Chen X, Gao M, et al.
Front Immunol
. 2024 Apr;
15:1304888.
PMID: 38605947
Background: Prior research has indicated a link between psoriasis and the susceptibility to breast cancer (BC); however, a definitive causal relationship remains elusive. This study sought to elucidate the causal...
3.
Huang J, Li X, Hong J, Huang L, Jiang Q, Guo S, et al.
Cancer Med
. 2023 May;
12(12):13599-13609.
PMID: 37184160
Background: Both inflammatory bowel disease (IBD) and hepato-pancreato-biliary cancers (HPBC) have been established to cause a huge socioeconomic burden. Epidemiological studies have revealed a close association between IBD and HPBC....
4.
Zhou R, Qiu B, Xiong M, Liu Y, Peng K, Luo Y, et al.
Int J Radiat Oncol Biol Phys
. 2023 Apr;
117(2):387-399.
PMID: 37100160
Purpose: We launched a prospective phase 2 clinical trial to explore the safety and efficacy of hypofractionated radiation therapy (hypo-RT) followed by hypofractionated boost (hypo-boost) combined with concurrent weekly chemotherapy...
5.
Huang J, Fan T, Rong Y, Li X, Jiang Q, Kan J, et al.
Eur J Clin Pharmacol
. 2023 Apr;
79(6):707-722.
PMID: 37043012
Objectives: This study aimed to assess the efficacy of Aidi combined with standard treatment, including radiotherapy (R), chemotherapy (C), or chemoradiotherapy (CR), for unresectable esophageal cancer (EC). Methods: Eight online...
6.
Huang J, Li X, Jiang Q, Qiu H, Rong Y, Cui B, et al.
Evid Based Complement Alternat Med
. 2023 Mar;
2023:2916974.
PMID: 36865748
Background: Negative regional lymph nodes do not indicate a lack of distant metastasis. A considerable number of patients with negative regional lymph node pancreatic cancer will skip the step of...
7.
Weng J, Lin X, Chen X, Liang Y, Xu Y, Cai J, et al.
Front Pharmacol
. 2022 Nov;
13:963892.
PMID: 36386193
In the Montreal classification, L4 Crohn's disease (CD) is defined as an ileal disease, including L4-esophagogastric duodenum (EGD), L4-jejunum, and L4-proximal ileal involvement. According to the previous studies, the prognosis...
8.
Kan J, Fu B, Zhou R, Zhou D, Huang Y, Zhao H, et al.
Phytomedicine
. 2021 Nov;
94:153821.
PMID: 34752967
Background: He-Chan Pian (HCP), a traditional Chinese medicinal formula, shows promising efficacy for the treatment of lung cancer. Purpose: Gremlin (GREM1) plays an important role in gastrointestinal tumor metastasis; however,...
9.
Wang X, Liu S, Cao H, Li X, Rong Y, Liu G, et al.
Pathol Oncol Res
. 2021 Jul;
27:587029.
PMID: 34257534
Nodal, an embryonic morphogen in TGF-β family, is related with tumorigenicity and progression in various tumors including colorectal cancer (CRC). However, the difference of Nodal expression between CRC and colorectal...
10.
Zhai W, Zheng Y, Rong Y, Li X, Yan Q, Duan F, et al.
J Thorac Dis
. 2021 May;
13(4):2184-2193.
PMID: 34012569
Background: The examination of lymph nodes (LNs) is critical for accurate node staging in patients with non-small cell lung cancer (NSCLC), but a consensus on the examinations of hilar and...